---
figid: PMC4107035__nihms583634f3
figtitle: PATHOGENETIC MECHANISMS OF FOCAL CORTICAL DYSPLASIA
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4107035
filename: nihms583634f3.jpg
figlink: /pmc/articles/PMC4107035/figure/F3/
number: F3
caption: The mTOR pathway can become hyperactive (thick lines) by mutations of genes
  encoding upstream regulators (TSC1, TSC2, STRADA, PTEN or NF-1), components of the
  pathways that converge on TCS1/2, such as RAF, AKT, PI3K and also of mTOR (highlighted
  in red). The recent discovery of HPV16 E6 in FCD type IIa and IIb along with other
  DNA viruses suggest that an infectious etiology can contribute to the pathogenesis
  of this condition. Together, activated mTOR pathway results in abnormally increased
  cell growth and proliferation that could account for the anatomical lesions encountered
  in cortical dysplasias. In addition, enhanced mTOR signaling can modify the expression
  of neurotransmitter receptors and ion channels, which can change membrane properties
  and synaptic organization leading to neuronal hyperexcitability. Both morphological
  and functional alterations at the cellular and circuit levels may lead to epilepsy,
  focal deficits and cognitive dysfunction in patients with cortical dysplasias.;
  ; ; ; ; ; ; ;
papertitle: PATHOGENETIC MECHANISMS OF FOCAL CORTICAL DYSPLASIA.
reftext: Isaac Marin-Valencia, et al. Epilepsia. ;55(7):970-978.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.950027
figid_alias: PMC4107035__F3
figtype: Figure
redirect_from: /figures/PMC4107035__F3
ndex: 4dd5aecd-def3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4107035__nihms583634f3.html
  '@type': Dataset
  description: The mTOR pathway can become hyperactive (thick lines) by mutations
    of genes encoding upstream regulators (TSC1, TSC2, STRADA, PTEN or NF-1), components
    of the pathways that converge on TCS1/2, such as RAF, AKT, PI3K and also of mTOR
    (highlighted in red). The recent discovery of HPV16 E6 in FCD type IIa and IIb
    along with other DNA viruses suggest that an infectious etiology can contribute
    to the pathogenesis of this condition. Together, activated mTOR pathway results
    in abnormally increased cell growth and proliferation that could account for the
    anatomical lesions encountered in cortical dysplasias. In addition, enhanced mTOR
    signaling can modify the expression of neurotransmitter receptors and ion channels,
    which can change membrane properties and synaptic organization leading to neuronal
    hyperexcitability. Both morphological and functional alterations at the cellular
    and circuit levels may lead to epilepsy, focal deficits and cognitive dysfunction
    in patients with cortical dysplasias.; ; ; ; ; ; ; ;
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - drk
  - Pten
  - Sos
  - Nf1
  - ras
  - Ras64B
  - Ras85D
  - Pdk1
  - Raf
  - Akt
  - Stlk
  - Lkb1
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Tsc1
  - SNF4Agamma
  - AMPKalpha
  - Rheb
  - Mtor
  - Tor
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GRB2
  - PTEN
  - XYLT2
  - SOS1
  - SOS2
  - STAMBP
  - NF1
  - KRAS
  - HRAS
  - NRAS
  - PDK1
  - PDPK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - STRADA
  - STK11
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - TSC1
  - CCL26
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - RHEB
  - RHEBP1
  - MTOR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
